GE Healthcare Launches Facility Validation Services
Will enable more efficient compliance for new or existing facilities
Piscataway, NJ, USA, May 11th, 2009 – GE Healthcare, a unit of General Electric Company (NYSE: GE), announces the launch of GE Healthcare Facility Validation Services, a new global service that will provide customers with more efficient and comprehensive international regulatory compliance for their facilities and manufacturing systems compared with complex traditional approaches.
Applicable to any new or existing facility, GE Healthcare Facility Validation Services uses a unique Modular Validation Platform to work with customers as they plan and design their facilities and manufacturing processes to the required regulatory standards. These new services leverage the latest regulatory trends and guidances, along with unique processes and systems to provide an improved regulatory compliance capability, with the potential to speed up product time-to-market.
GE Healthcare Facility Validation Services will employ the Company’s extensive project and business management expertise, as well as operational excellence methodologies such as Lean and Six Sigma, to provide a world-class integrated global service. Victor Bornsztejn, Global Growth Director, GE Healthcare, states: “We aim to help eliminate the current disconnection between drug/process development and facility validation. GE Healthcare has played a pivotal role in biopharmaceutical drug and process development for decades, so we believe we are uniquely positioned to drive this change in the industry.”
“The launch of GE Healthcare Facility Validation Services is a major milestone for GE Healthcare, combining many of the Company’s capabilities,” adds Mr. Bornsztejn. “Drug manufacturers are regularly receiving citations and warnings that are linked to their validation, usually for reasons that are easily avoidable. We believe our range of solutions and expertise enables us to offer a very broad range of complete product/lifecycle services at a time when compliance and cost-containment are key industry concerns.”
For more information please visit: www.gelifesciences.com/validation
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com

